The National Comprehensive Cancer Network (NCCN) has recently changed its mesothelioma treatment guidelines to help improve patient life expectancy. Adding the monoclonal antibody bevacizumab to [...]
P2RX7 is a protein-coding gene that is expressed by mesothelioma cancer cells. A new study is looking into medications that might block P2X7R and inhibit [...]
A recently identified blood biomarker, activin A, may prove useful in the early detection of mesothelioma. Equally promising, this new biomarker may even allow [...]
Renal cell carcinoma occurs in the lining of the proximal convoluted tubule – part of the tubes in the kidneys responsible for transporting waste molecules. [...]
